TWD 9.83
(2.72%)
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2023 | 5.6 Million TWD | 0.0% |
2022 | - TWD | -100.0% |
2021 | 2.52 Million TWD | -49.67% |
2020 | 5.02 Million TWD | 0.0% |
2019 | - TWD | 0.0% |
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2024 Q2 | 4.28 Million TWD | 0.0% |
2024 Q1 | 4.28 Million TWD | 0.0% |
2023 Q1 | - TWD | 0.0% |
2023 Q2 | - TWD | 0.0% |
2023 FY | 5.6 Million TWD | 0.0% |
2023 Q4 | 5.6 Million TWD | 0.0% |
2023 Q3 | 5.6 Million TWD | 0.0% |
2022 Q3 | - TWD | 0.0% |
2022 Q4 | - TWD | 0.0% |
Name | Long Term Debt | Long Term Debt Difference |
---|---|---|
SYN-TECH Chem. & Pharm. Co., Ltd. | 60.65 Million TWD | 90.762% |
Level Biotechnology Inc. | 9.88 Million TWD | 43.318% |
Sagittarius Life Science Corp | 6.25 Million TWD | 10.409% |
NeoCore Technology Co., Ltd. | 33.65 Million TWD | 83.35% |
TaiMed Biologics Inc. | 521.7 Million TWD | 98.926% |
GlycoNex Incorporation | - TWD | -Infinity% |
VBI | - TWD | -Infinity% |
GeneReach Biotechnology Corp. | 97.74 Million TWD | 94.268% |
Taiwan Advance Bio-Pharmaceutical Inc. | 86.89 Million TWD | 93.552% |
Visgeneer Inc. | 114.17 Million TWD | 95.093% |
Mycenax Biotech Inc. | 569.78 Million TWD | 99.017% |
Sunmax Biotechnology Co., Ltd. | 144.77 Million TWD | 96.13% |
G&E Herbal Biotechnology Co., Ltd. | 1.29 Million TWD | -332.998% |
Medigen Vaccine Biologics Corporation | 254.35 Million TWD | 97.797% |
TaiwanJ Pharmaceuticals Co., Ltd. | 472 Thousand TWD | -1087.076% |
Enimmune corporation | 1.75 Million TWD | -218.533% |
TaiRx, Inc. | 8.96 Million TWD | 37.529% |
CHO Pharma, Inc. | - TWD | -Infinity% |
EirGenix Inc. | 436.54 Million TWD | 98.717% |
BioLASCO Taiwan Co., Ltd. | 51.43 Million TWD | 89.106% |
Sunny Pharmtech Inc. | 376.29 Million TWD | 98.511% |
Lin BioScience, Inc. | 29.02 Million TWD | 80.697% |
BioGend Therapeutics Co., Ltd. | 9.44 Million TWD | 40.652% |
Feng Chi Biotech Corp. | 8.14 Million TWD | 31.243% |
Bio Preventive Medicine Corp. | 106.2 Million TWD | 94.724% |
Lukas Biomedical Inc. | 69.9 Million TWD | 91.985% |
RBC Bioscience Corporation | 412.59 Million TWD | 98.642% |
BiOptic Inc. | 85.79 Million TWD | 93.469% |
BRIM Biotechnology, Inc. | 108 Thousand TWD | -5087.963% |
Shine-On BioMedical Co.,Ltd. | - TWD | -Infinity% |
Great Novel Therapeutics Biotech & Medicals | 10.88 Million TWD | 48.507% |
Syngen Biotech Co.,Ltd. | 386.07 Million TWD | 98.549% |
Anti-Microbial Savior BioteQ Co., Ltd | - TWD | -Infinity% |
SynCore Biotechnology Co.,Ltd | - TWD | -Infinity% |
Genomics BioSci & Tech. Co.,Ltd. | 222.24 Million TWD | 97.479% |
Neith Corporation | 714 Thousand TWD | -684.734% |
Advagene Biopharma Co., Ltd. | - TWD | -Infinity% |
NaviFUS Corp. | 25.83 Million TWD | 78.314% |
Gwo Xi Stem Cell Applied Technology Co. , Ltd | 366 Million TWD | 98.469% |
Sinew Pharma Inc. | - TWD | -Infinity% |
Andros Pharmaceuticals Co.,Ltd | 22.02 Million TWD | 74.56% |
Greenyn Biotechnology Co., Ltd | 55.91 Million TWD | 89.98% |
Lumosa Therapeutics Co., Ltd. | 8.11 Million TWD | 30.972% |
AP Biosciences Inc | 70.42 Million TWD | 92.044% |
Medigen Biotechnology Corp. | 449.09 Million TWD | 98.752% |
3D Global Biotech Inc. | 4.08 Million TWD | -37.261% |
Pharmosa Biopharm Inc. | 118.41 Million TWD | 95.268% |
Intech Biopharm Corporation | 970.4 Million TWD | 99.423% |
Oneness Biotech Co., Ltd. | 397.95 Million TWD | 98.592% |
Eusol Biotech Co.,Ltd. | 1.6 Million TWD | -248.879% |
Ever Supreme Bio Technology Co., Ltd | 503 Thousand TWD | -1013.917% |
TCI GENE Inc. | - TWD | -Infinity% |
MegaPro Biomedical Co., Ltd | 5.62 Million TWD | 0.444% |
Senhwa Biosciences, Inc. | 3.28 Million TWD | -70.459% |
Taiwan Bio Therapeutics Co., Ltd | 250.51 Million TWD | 97.763% |
NatureWise Biotech & Medicals Corporation | 3.26 Million TWD | -71.608% |
PharmaEngine, Inc. | 7.14 Million TWD | 21.56% |
Savior Lifetec Corporation | 257.03 Million TWD | 97.82% |
TaiGen Biopharmaceuticals Holdings Limited | 58.71 Million TWD | 90.456% |
OBI Pharma, Inc. | 439.88 Million TWD | 98.726% |
Meribank Biotech Co., Ltd | 14.81 Million TWD | 62.17% |
Acepodia, Inc. | 233.45 Million TWD | 97.6% |
Caliway Biopharmaceuticals Co., Ltd. | 11.87 Million TWD | 52.813% |